RADIUS GLOBAL INFRASTRUCTURE INC RADI 深 滬
已收盤 09-21 16:00:00 美东时间
15.00
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 15.00
- 總市值 14.96亿
- 52周最高 15.18
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 7.97
- 委 比 0.00%
- 總股本 9971.70万
- 歷史最高 18.79
- 量 比 0
- 振 幅 0.00%
- 歷史最低 6.57
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Music Broadcast Ltd. Faces High Court Order on Royalty Calculations
An announcement from Music Broadcast Ltd. ( ($IN:RADIOCITY) ) is now available....
08-27 02:03
Praxis Precision Medicines To Present 12 Epilepsy Pipeline Updates, Including RADIANT Results, At IEC 2025 In Lisbon
Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in the upcoming
08-26 04:02
Radico Khaitan to Engage with Investors in Upcoming Conferences
Radico Khaitan Limited ( ($IN:RADICO) ) just unveiled an update. Radico Khaitan...
08-17 17:03
Praxis Announces Positive Results from RADIANT Study
An update from Praxis Precision Medicines ( ($PRAX) ) is now available. On Augu...
08-04 21:18
Guardant Health Study Shows Blood Test Detects Immunotherapy Response Early Across Multiple Cancer Types; Guardant Reveal Identified Non-Responders Up To 5 Months Before Standard Methods, Supporting Faster, More Effective Treatment Decisions In Advanced Cancer Care.
The first readout from Guardant's research collaboration with the Parker Institute for Cancer Immunotherapy (PICI) shows Guardant Reveal detected responses to immunotherapy across multiple tumor types and identified
07-29 20:09
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
Radiopharm Theranostics announced financial results for FY2025 and provided updates on its pipeline. Key highlights include: - On track to complete enrollment of first two cohorts for RAD204 at 60mCi dose. - Initiated Phase 1 HEAT trial for RAD202 targeting HER2-positive tumors. - FDA granted Fast Track Designation for RAD101 to assess brain metastases. - Secured supply agreements for key radioisotopes and expanded clinical trials. - Y...
07-29 11:30
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
Radiopharm Theranostics has appointed Dr. Oliver Sartor, a leading medical oncologist specializing in prostate cancer and radiopharmaceutical therapies, to its Scientific Advisory Board. Dr. Sartor, who serves at the Mayo Clinic, has contributed significantly to the field with over 500 publications and pivotal FDA-approved therapies. His expertise will support the company's oncology radiopharmaceutical pipeline development.
07-22 12:00
Radico Khaitan Schedules 41st AGM with E-Voting Facility
Radico Khaitan Limited ( ($IN:RADICO) ) has provided an update. Radico Khaitan ...
07-16 11:44
Radico Khaitan Emphasizes ESG in Latest Sustainability Report
The latest announcement is out from Radico Khaitan Limited ( ($IN:RADICO) ). Ra...
07-16 11:44
[ESP-IDF系列]使用ESP32驱动NRF24L01实现单点通讯
本文引用地址： 1 简介 最近想DIY一个四轴飞行器（简易的十字形遥控飞行器），也从晚上找了很多的视频和做了相关的简易研究（如果搞出来了...
06-29 15:24
